Skip to main content

Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions

Journal of Thrombosis and Thrombolysis volume 21, pages 167–174 (2006)Cite this article

Abstract

For many years, the traditional treatment for hospitalized patients in the United States who have developed anemia, whether associated with medical illness, surgical procedures or trauma, has been red blood cell transfusion, despite the absence of supporting data in many patient populations. Emerging evidence suggests that transfusions may, in fact, be associated with risk beyond commonly held concerns of microbial transmission and acute antigen-antibody reactions. The following overview represents a biological paradigm for understanding the relationship between medical illness, surgical procedures, inflammatory states, anemia, red blood cell transfusion and immunothrombotic phenomena among hospitalized patients.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Rodriguez RM, Corwin HL, Getteinger A, Corwin MJ, Gubler D, Pearl RG (2001) Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 16:36–41

    Article  CAS  PubMed  Google Scholar 

  2. Poveda Gomez F, Camacho Siles J, Quevedo Morales E, et al. (2001) Pattern of blood levels of erythropoietin and proinflammatory cytokines in patients with anemia of chronic disease secondary to infection. Ann Med In 18:298–304

    CAS  Google Scholar 

  3. Corwin HL, Krantz SB (2000) Anemia of the critiacally ill: “acute” anemia of chronic disease. Crit Care Medicine 28:3098–3099

    Article  CAS  Google Scholar 

  4. Andre P, Prasad KS, Denis CV, et al. (2002) CD40L stabilizes arterial thrombi by a beta3 integrin–dependent mechanism. Nature Medicine 8;247–252

    Article  CAS  PubMed  Google Scholar 

  5. Aukrust P, Muller F, Ueland T, et al. (1999) Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100:614–620

    Article  CAS  PubMed  Google Scholar 

  6. Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS (2002) Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 106:2372–2378

    Article  CAS  PubMed  Google Scholar 

  7. Devaraj S, Xu DY, Jialal I (2003) C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107:398–404

    Article  CAS  PubMed  Google Scholar 

  8. Eren M, Painter CA, Atkinson JB, Declerck PJ, Vaughan DE (2002) Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation 106:491–496

    Article  CAS  PubMed  Google Scholar 

  9. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394:200–203

    Article  CAS  PubMed  Google Scholar 

  10. Schafer K, Muller K, Hecke A, et al. (2003) Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. Arterioscl, Thromb Vasc Biol 23:2097–2103

    Article  Google Scholar 

  11. Schonbeck U, Mach F, Sukhova GK, et al. (1997) Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by t lymphocytes. Circ Res 81:448–454

    CAS  Google Scholar 

  12. Siren V, Kauhanen P, Carpen O, et al. (2003) Urokinase, tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis. Blood Coag Fibrinol 14:369–377

    Article  CAS  Google Scholar 

  13. Urbich C, Dernbach E, Aicher A, Zeiher AM, Dimmeler S. (2002) CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106:981–986

    Article  CAS  PubMed  Google Scholar 

  14. Levy PS, Kim SJ, Eckel PK, et al. (1993) Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol 265:H340–H349

    CAS  PubMed  Google Scholar 

  15. Taylor JE, Henderson IS, Stewart WK, Belch JJ (1991) Erythropoietin and spontaneous platelet aggregation in haemodialysis patients. Lancet 338;1361–1362

    Article  CAS  PubMed  Google Scholar 

  16. Smith KJ, Bleyer AJ, Little WC, Sane DC (2003) The cardiovascular effects of erythropoietin. Cardiovasc Res 59:538–548

    CAS  Google Scholar 

  17. Carson JL, Duff A, Poses RM, et al. (1996) Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348:1055–1060

    Article  CAS  PubMed  Google Scholar 

  18. Carson JL, Noveck H, Berlin JA, Gould SA (2002) Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 42:812–818

    Article  PubMed  Google Scholar 

  19. Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer; a systematic review of the literature. Am J Med 116(Suppl 7A):11S–26S

    Google Scholar 

  20. Mozaffarian D, Nye R, Levy WC (2003) Anemia predicts mortality in severe heart failure; the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 41:1933–1939

    Article  PubMed  Google Scholar 

  21. Corwin HL, Gettinger A, Pearl RG, et al. (2004) the CRIT Study. Anemia and blood transfusion in the critically ill–-current clinical practice in the United States. Crit Care Med 32:39–52

    Article  PubMed  Google Scholar 

  22. Adam RC, Lundy JS (1942) Anesthesia in cases of poor risk: Some suggestion for decreasing the risk. Surg Gynocol Obstet 74:1011–1101

    Google Scholar 

  23. Shander A (2004) Anemia in the critically ill. Crit Care Clin 20:159–178

    Article  PubMed  Google Scholar 

  24. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC, O’Hara DA, Noveck H, Strom BL (1998) Perioperative blood transfusion and postoperative mortality. JAMA 279:199–205

    Article  CAS  PubMed  Google Scholar 

  25. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM (2001) Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345:1230–1236

    Article  CAS  PubMed  Google Scholar 

  26. Hebert PC, Yetisir E, Martin C, et al. (2001) Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 29:227–234

    Article  CAS  PubMed  Google Scholar 

  27. Rao SV, Jollis JG, Harrington RA, et al. (2004) Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary Syndromes. JAMA 292:1555–1562

    Article  CAS  PubMed  Google Scholar 

  28. Hebert PC, Wells G, Blajchman MA, et al. (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417

    Article  CAS  PubMed  Google Scholar 

  29. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM (2003) Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54:898–907

    Article  PubMed  Google Scholar 

  30. Vincent JL, Baron JF, Reinhart K, et al. (2002) ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA 288:1499–1507

    Article  PubMed  Google Scholar 

  31. Blumberg N (1997) Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 34(3 Suppl 2):34–40

    Google Scholar 

  32. Anderson CB, Tyler JD, Rodey GE, et al. (1987) Peroperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions. Transplant Proc. 19(1 Pt 2):1494–1497

    CAS  PubMed  Google Scholar 

  33. Karamloiu T, Schultz JM, Silliman C, et al. (2005) Using a miniaturized circuit and an asanguineous prime to reduce neutrophil-mediated organ dysfunction following infant cardiopulmonary bypass. Ann Thorac Surg 80(1):6–13; discussion 13–14

    Google Scholar 

  34. Toy P, Popovsky MA, Abraham E. et al. (2005) National Heart, Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med 33(4)721–726

    Article  PubMed  Google Scholar 

  35. Silliman CC, Ambruso DR, Boshkov LK (2005) Transfusion-related acute lung injury. Blood 105(6):2266–2273

    Article  CAS  PubMed  Google Scholar 

  36. Vamvakas EC (2002) Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfusion Med Rev 16:304–314

    Article  Google Scholar 

  37. Ho J, Sibbald WJ, Chin-Yee IH (2003) Effects of storage on efficacy of red cell transfusion: when is it not safe? Crit Care Med 31(12 Suppl):S687–S697

    Google Scholar 

  38. Nielsen HJ, Edvardsen L, Brunner N, et al. (1996) Time-dependent, spontaneous release of leukocyte and platelet derived bioactive substances from stored human blood. Transfusion 36:960–965

    Article  CAS  PubMed  Google Scholar 

  39. van de Watering LM, Hermans J, Houbiers JG, et al. (1998) Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 97:562–568

    Article  PubMed  Google Scholar 

  40. Biedler AE, Schneider SO, Seyfert U, et al. (2002) Impact of alloantigens and storage-asssociated factors on stimulated cytokine response in an in vitro model of blood transfusion. Anesthesiology 97:1102–1109

    Article  CAS  PubMed  Google Scholar 

  41. Klein HG (2003) Getting older is not necessarily getting better. Anesthesiology 98:807–808

    Article  PubMed  Google Scholar 

  42. Sparrow RL, Patton KA (2004) Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 44:722–730

    Article  CAS  PubMed  Google Scholar 

  43. Schonbeck U, Varo N, Libby P, Buring J, Ridker PM (2001) Soluble CD40L and cardiovascular risk in women. Circulation 104:2266–2268

    Article  CAS  PubMed  Google Scholar 

  44. Sabovic M, Zorman SK (2003) Plasminogen activator inhibitor-1, which is released from blood product transfusions, might be associated with (sub)acute thrombosis after coronary dilatation and stenting: a case report. Heart Vessels 18:47–49

    Article  PubMed  Google Scholar 

  45. Nielsen HJ, Reimert C, Pedersen AN, et al. (1997) Leucocyte-derived bioactive substances in fresh frozen plasma. Br J Anaesth 78:548–552

    Article  CAS  PubMed  Google Scholar 

  46. Hedstrom M, Flordal PA, Ahl T, Svensson J, Dalen N (1996) Autologous blood transfusion in hip replacement. No effect on blood loss but less increase of plasminogen activator inhibitor in a randomized series of 80 patients. Acta Orthop Scand 67:317–320

    Article  CAS  PubMed  Google Scholar 

  47. Pawloski JR, Stamler JS (2002) Nitric oxide in RBCs. Transfusion 42:1603–1609

    Article  CAS  PubMed  Google Scholar 

  48. Bor-Kucukatay M, Wenby RB, Meiselman HJ, Baskurt OK (2003) Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 284:H1577–1584

    CAS  PubMed  Google Scholar 

  49. Tsai AG, Cabrales P, Intaglietta M (2004) Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions. Transfusion 44:1626–1634

    Article  PubMed  Google Scholar 

  50. Xiao Z, Theroux P (2004) Clopidogrel inhibits platelet-leukocyte interaction and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. J Am Coll Cardiol 43:1982–1988

    Article  CAS  PubMed  Google Scholar 

  51. Tinmouth A, Macdougall L, Fergusson D, et al. Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians’ transfusion practices.

  52. Eindhoven GB, Diercks RL, Richardson FJ, et al. (2005) Adjusted transfusion triggers improve transfusion practice in orthopaedic surgery. Transfus Med 15(1):13–18

    Article  CAS  PubMed  Google Scholar 

  53. Wautier JL, Cabaud JJ, Cazenave JP, et al. (2005) College des enseignants en transfusion sanguine. [French training program for medical students in transfusion medicine. Transfusion Medicine Teachers’ College]. Transfus Clin Biol 12(1):59–69

    Article  PubMed  Google Scholar 

  54. Hervig T, Flesland O, Svenningsen V, Bosnes V (2004) Guidelines for transfusion in Norway. Transfus Apheresis Sci 3198:181–184

    Article  Google Scholar 

  55. Potocnik M (2005) Transposing the E.E.U. Blood directive into national law. Perspective of Slovenia. Transfus Clin Biol 12(1):21–24

    Article  PubMed  Google Scholar 

  56. Dickinson T, Riley J, Steg A, Zabetakis P (2004) Observations from a national multiple institution autotransfusion (ATS) quality indicator program. J Extra Corpor Technol 36(2):153–157

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Duke University Medical Center, Cardiovascular Thrombosis Center, Duke Clinical Research Institute, Durham, NC, 27715

    Katie M. Twomley, Sunil V. Rao & Richard C. Becker

Authors
  1. Katie M. Twomley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sunil V. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard C. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard C. Becker.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Twomley, K.M., Rao, S.V. & Becker, R.C. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis 21, 167–174 (2006). https://doi.org/10.1007/s11239-006-5206-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-006-5206-4

Keywords

  • Anemia
  • Thrombosis
  • Transfusion